Cargando…

Growth and hormone profiling in children with congenital melanocytic naevi

BACKGROUND: Multiple congenital melanocytic naevi (CMN) is a rare mosaic RASopathy, caused by postzygotic activating mutations in NRAS. Growth and hormonal disturbances are described in germline RASopathies, but growth and hormone status have not previously been investigated in individuals with CMN....

Descripción completa

Detalles Bibliográficos
Autores principales: Waelchli, R., Williams, J., Cole, T., Dattani, M., Hindmarsh, P., Kennedy, H., Martinez, A., Khan, S., Semple, R.K., White, A., Sebire, N., Healy, E., Moore, G., Kinsler, V.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737097/
https://www.ncbi.nlm.nih.gov/pubmed/26286459
http://dx.doi.org/10.1111/bjd.14091
_version_ 1782413417416491008
author Waelchli, R.
Williams, J.
Cole, T.
Dattani, M.
Hindmarsh, P.
Kennedy, H.
Martinez, A.
Khan, S.
Semple, R.K.
White, A.
Sebire, N.
Healy, E.
Moore, G.
Kinsler, V.A.
author_facet Waelchli, R.
Williams, J.
Cole, T.
Dattani, M.
Hindmarsh, P.
Kennedy, H.
Martinez, A.
Khan, S.
Semple, R.K.
White, A.
Sebire, N.
Healy, E.
Moore, G.
Kinsler, V.A.
author_sort Waelchli, R.
collection PubMed
description BACKGROUND: Multiple congenital melanocytic naevi (CMN) is a rare mosaic RASopathy, caused by postzygotic activating mutations in NRAS. Growth and hormonal disturbances are described in germline RASopathies, but growth and hormone status have not previously been investigated in individuals with CMN. OBJECTIVES: To explore premature thelarche, undescended testes, and a clinically abnormal fat distribution with CMN through prospective endocrinological assessment of a cohort of subjects with CMN, and a retrospective review of longitudinal growth of a larger group of patients with CMN from outpatient clinics (which included all subjects in the endocrinological assessment group). PATIENTS AND METHODS: Longitudinal growth in a cohort of 202 patients with single or multiple CMN was compared with the U.K. National Child Measurement Programme 2010. Forty‐seven children had hormonal profiling including measurement of circulating luteinizing hormone, follicle‐stimulating hormone, thyroid stimulating hormone, adrenocorticotrophic hormone, growth hormone, prolactin, pro‐opiomelanocortin, estradiol, testosterone, cortisol, thyroxine, insulin‐like growth factor‐1 and leptin; 10 had oral glucose tolerance testing 25 had dual‐energy X‐ray absorptiometry scans for body composition. RESULTS: Body mass index increased markedly with age (coefficient 0·119, SE 0·016 standard deviation scores per year), at twice the rate of the U.K. population, due to increased adiposity. Three per cent of girls had premature thelarche variant and 6% of boys had persistent undescended testes. Both fat and muscle mass were reduced in areas underlying large naevi, resulting in limb asymmetry and abnormal truncal fat distribution. Anterior pituitary hormone profiling revealed subtle and variable abnormalities. Oral glucose tolerance tests revealed moderate–severe insulin insensitivity in five of 10, and impaired glucose tolerance in one. CONCLUSIONS: Interpersonal variation may reflect the mosaic nature of this disease and patients should be considered individually. Postnatal weight gain is potentially related to the underlying genetic defect; however, environmental reasons cannot be excluded. Naevus‐related reduction of fat and muscle mass suggests local hormonal or metabolic effects on development or growth of adjacent tissues, or mosaic involvement of these tissues at the genetic level. Premature thelarche and undescended testes should be looked for, and investigated, as for any child.
format Online
Article
Text
id pubmed-4737097
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47370972016-02-11 Growth and hormone profiling in children with congenital melanocytic naevi Waelchli, R. Williams, J. Cole, T. Dattani, M. Hindmarsh, P. Kennedy, H. Martinez, A. Khan, S. Semple, R.K. White, A. Sebire, N. Healy, E. Moore, G. Kinsler, V.A. Br J Dermatol Original Articles BACKGROUND: Multiple congenital melanocytic naevi (CMN) is a rare mosaic RASopathy, caused by postzygotic activating mutations in NRAS. Growth and hormonal disturbances are described in germline RASopathies, but growth and hormone status have not previously been investigated in individuals with CMN. OBJECTIVES: To explore premature thelarche, undescended testes, and a clinically abnormal fat distribution with CMN through prospective endocrinological assessment of a cohort of subjects with CMN, and a retrospective review of longitudinal growth of a larger group of patients with CMN from outpatient clinics (which included all subjects in the endocrinological assessment group). PATIENTS AND METHODS: Longitudinal growth in a cohort of 202 patients with single or multiple CMN was compared with the U.K. National Child Measurement Programme 2010. Forty‐seven children had hormonal profiling including measurement of circulating luteinizing hormone, follicle‐stimulating hormone, thyroid stimulating hormone, adrenocorticotrophic hormone, growth hormone, prolactin, pro‐opiomelanocortin, estradiol, testosterone, cortisol, thyroxine, insulin‐like growth factor‐1 and leptin; 10 had oral glucose tolerance testing 25 had dual‐energy X‐ray absorptiometry scans for body composition. RESULTS: Body mass index increased markedly with age (coefficient 0·119, SE 0·016 standard deviation scores per year), at twice the rate of the U.K. population, due to increased adiposity. Three per cent of girls had premature thelarche variant and 6% of boys had persistent undescended testes. Both fat and muscle mass were reduced in areas underlying large naevi, resulting in limb asymmetry and abnormal truncal fat distribution. Anterior pituitary hormone profiling revealed subtle and variable abnormalities. Oral glucose tolerance tests revealed moderate–severe insulin insensitivity in five of 10, and impaired glucose tolerance in one. CONCLUSIONS: Interpersonal variation may reflect the mosaic nature of this disease and patients should be considered individually. Postnatal weight gain is potentially related to the underlying genetic defect; however, environmental reasons cannot be excluded. Naevus‐related reduction of fat and muscle mass suggests local hormonal or metabolic effects on development or growth of adjacent tissues, or mosaic involvement of these tissues at the genetic level. Premature thelarche and undescended testes should be looked for, and investigated, as for any child. John Wiley and Sons Inc. 2015-11-17 2015-12 /pmc/articles/PMC4737097/ /pubmed/26286459 http://dx.doi.org/10.1111/bjd.14091 Text en © 2015 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Waelchli, R.
Williams, J.
Cole, T.
Dattani, M.
Hindmarsh, P.
Kennedy, H.
Martinez, A.
Khan, S.
Semple, R.K.
White, A.
Sebire, N.
Healy, E.
Moore, G.
Kinsler, V.A.
Growth and hormone profiling in children with congenital melanocytic naevi
title Growth and hormone profiling in children with congenital melanocytic naevi
title_full Growth and hormone profiling in children with congenital melanocytic naevi
title_fullStr Growth and hormone profiling in children with congenital melanocytic naevi
title_full_unstemmed Growth and hormone profiling in children with congenital melanocytic naevi
title_short Growth and hormone profiling in children with congenital melanocytic naevi
title_sort growth and hormone profiling in children with congenital melanocytic naevi
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737097/
https://www.ncbi.nlm.nih.gov/pubmed/26286459
http://dx.doi.org/10.1111/bjd.14091
work_keys_str_mv AT waelchlir growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT williamsj growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT colet growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT dattanim growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT hindmarshp growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT kennedyh growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT martineza growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT khans growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT semplerk growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT whitea growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT sebiren growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT healye growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT mooreg growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi
AT kinslerva growthandhormoneprofilinginchildrenwithcongenitalmelanocyticnaevi